MAKO Surgical Corp. (NASDAQ:MAKO)
CAPS Rating:
Mako makes a robotic surgical system for knee and hip arthoplasty procedures.
The World's Greatest Investing Community
Mako makes a robotic surgical system for knee and hip arthoplasty procedures.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
I just got MAKO @ 14.76 in RL. According to the AH CC, the deal flow has slowed down as hospitals are getting more risk averse and want to understand their ROI by looking at more doctors to be part of the Makoplasty program. Since their platform is still strong, and since more surgeons are training in this system, I'm sticking with MAKO for the long run.